Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
13:29:55 EDT Thu 18 Apr 2024
Enter Symbol
or Name
USA
CA



Z:MNK - MALLINCKRODT PLC - http://www.mallinckrodt.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MNK - ZHALTED0.3402    18.10  0.30Aug 25Mar 2615 min RT 2¢

Recent Trades - All 0 today
Time ETExPriceChangeVolume
     
     
     
     
     
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-03-26 16:01U:MNKNews ReleaseMallinckrodt plc Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides 2024 Guidance
2024-03-11 06:52U:MNKNews ReleaseMallinckrodt Announces Journal Publication of Real-World Data on Acthar(TM) Gel (repository corticotropin injection) to Treat Symptomatic Sarcoidosis in African American and Non-African American Patients
2024-03-04 06:45U:MNKNews ReleaseMallinckrodt Announces Appointment of Paul O'Neill as Executive Vice President, Quality & Operations, Specialty Brands
2024-03-01 08:50U:MNKNews ReleaseMallinckrodt Announces U.S. FDA Approval of Supplemental New Drug Application for Acthar(TM) Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect(TM) Injector
2024-02-02 08:45U:MNKNews ReleaseMallinckrodt Announces Board of Directors and Leadership Updates
2024-01-22 06:52U:MNKNews ReleaseMallinckrodt Presents New Data on TERLIVAZ ‚ ® (terlipressin) for Injection at the Society of Critical Care Medicine (SCCM) 2024 Critical Care Congress
2023-11-01 06:45U:MNKNews ReleaseMallinckrodt to Present Data on TERLIVAZ ‚ ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2023 Scientific Meeting
2023-10-26 06:53U:MNKNews ReleaseMallinckrodt Presents Latest Health Economics Data on Acthar ‚ ® Gel (Repository Corticotropin Injection) at the Academy of Managed Care Pharmacy (AMCP) Nexus 2023
2023-08-30 11:54U:MNKNews ReleaseMallinckrodt Receives Court Approval for "First Day" Motions to Support Ongoing Operations
2023-08-28 00:17U:MNKNews ReleaseMallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations
2023-08-23 08:22U:MNKNews ReleaseMallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring Plan
2023-08-09 06:45U:MNKNews ReleaseMallinckrodt plc Reports Second Quarter 2023 Financial Results and Reaffirms Full Year Guidance
2023-06-15 06:52U:MNKNews ReleaseMallinckrodt to Present Data on TERLIVAZ ‚ ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the European Association for the Study of the Liver (EASL) Congress 2023
2023-06-01 06:52U:MNKNews ReleaseMallinckrodt Presents Clinical Data for TERLIVAZ ‚ ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at the American Transplant Congress (ATC) 2023
2023-05-09 06:45U:MNKNews ReleaseMallinckrodt plc Reports First Quarter 2023 Financial Results and Reaffirms Full Year Guidance
2023-05-08 06:52U:MNKNews ReleaseMallinckrodt Presents Clinical Data for TERLIVAZ ‚ ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS) at Digestive Disease Week (DDW) 2023
2023-05-05 06:52U:MNKNews ReleaseMallinckrodt Recognized as Industry Innovator at National Organization for Rare Disorders (NORD) 2023 Rare Impact Awards
2023-04-28 08:00U:MNKNews ReleaseBuxton Helmsley Issues Letter to Mallinckrodt Plc. Regarding Failure to Address Evidential Multibillion-Dollar Asset Value Depreciation Expense Concealment Scheme
2023-04-24 06:45U:MNKNews ReleaseMallinckrodt to Report Earnings Results for First Quarter 2023